The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Congressionally Directed Medical Research Programs (CDMRP) -- Autism Research Program (ARP) -- Clinical Translational Research Award
The ARP Clinical Translational Research Award is intended to support early-phase, proof-ofprinciple translational studies that will examine hypothesis-based, innovative interventions that have the potential to address current clinical deficits for ASD. Applications are strongly encouraged to address one of the ARP Clinical Translational Research Award Areas of Interest. If the proposed project does not address any of the FY19 ARP Clinical Translational Research Award Areas of Interest, the application should describe how the project will nevertheless address a critical need of the ASD community. Outcomes from studies funded by this award are anticipated to provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform ASD clinical care.
Projects are required to involve human subjects. Projects that are strictly animal research aimed at developing or refining new technology and research to establish the efficacy/ effectiveness of diagnostic agents are not allowed under this funding opportunity. The proposed studies should include early-phase, proof-of-principle studies using human subjects. The proposed studies may be interventional, including Phase 0 clinical trials or single-group intervention studies, and may involve some retrospective data analysis; however, purely retrospective or database-related research is not allowed.
• Pre-Application Deadline: May 1, 2019
• Invitation to Submit an Application: June 2019
• Application Submission Deadline: August 8, 2019
Areas of Interest
The FY19 ARP Clinical Translational Research Award seeks applications for early-phase clinical research, and strongly encourages applications that address the critical needs of the ASD community in one or more of the following areas of interest: • Behavioral, cognitive, and other non-pharmacological therapies for ASD core symptoms or to alleviate co-occurring conditions • Pharmacological, genetic, and other biological treatments for ASD core symptoms or to alleviate co-occurring conditions • Dissemination/implementation of clinically validated interventions • Improve diagnosis and access to services across the life span • Interventions promoting success in key transitions to adulthood for individuals living with ASD • Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief) • Cultural, socioeconomic, and gender factors in diagnosis, treatment efficacy, delivery, and access to services
Investigators at or above the level of Assistant Professor (or equivalent) may be named by the organization as the PI on the application. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization.
The anticipated direct costs budgeted for the entire period of performance for an FY19 ARP Clinical Translational Research Award will not exceed $500,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.